Xilam Extends Oggy into Mobile Games with Nazara Partnership
Xilam Animation (Paris:XIL) is further boosting the Oggy & the Cockroaches brand into gaming with the appointment of Nazara Technologies Ltd, a global mobile game company, in a deal brokered via Xilam and licensing agent, Dream Theatre.
Nazara will launch a raft of new captivating mobile games for younger audiences that underscore the hilarious, entertaining brand values of Oggy & the Cockroaches. The first game is expected to be available in the first quarter of 2018 in Asia Pacific, Latin America and Middle East.
With an ever-growing digital landscape, Oggy & the Cockroaches is reaching new heights and raking up exceptional results on digital platforms throughout the world. The series has a cult following on Facebook with more than 3.5M fans and 1.2M subscribers on YouTube. Partnering with Nazara is only a natural extension of the brand experience.
Marc du Pontavice, Founder and President of Xilam said: “Xilam is eager to expand the presence of its properties in the digital domain. Nazara is one of the leaders in the mobile gaming arena and we’re thrilled to be working together to take Oggy and his friends to new heights in gaming. We’re excited to give kids yet another avenue to become immersed in his cheeky world as we celebrate 20 years of Oggy & the Cockroaches.”
Nazara is one of the leading mobile games company’s in India's digital landscape, operating in 61 countries across emerging markets, as of September 30, 2017. In India, Nazara has licensed mobile gaming rights to popular kids IPs including Chhota Bheem, Motu Patlu, Mighty Raju, Tinkle characters and Chacha Choudhary among other IP’s including Virat Kohli, Royal Challengers Bangalore and Hrithik Roshan.
Manish Agarwal, CEO, Nazara Technologies said: “With Oggy & the Cockroaches, Nazara will continue to deliver high-quality games for the global market. We have built a strong portfolio of successful games which have targeted young audiences in India over the last two years and now with the Oggy & the Cockroaches IP, we can reach audiences across emerging markets beyond India, by leveraging the global appeal of the show. ”
Cartoon Network Asia has scooped up seasons five, six and seven of the series for its channels this year, with previous seasons of Oggy currently running on Nickelodeon, Youku in China and Netflix Asia Pacific (outside China and India).
In India, Oggy & the Cockroaches currently airs on both Cartoon Network and Nickelodeon, as well as on Amazon Prime. The series is also available on Cartoon Network Latin America and on Cartoon Network Middle East and Africa (MENA), and Gulli Bil Arabi.
The series is distributed in more than 160 countries around the world and is watched in 600 million homes.
Xilam is one of Europe’s leading animation companies, producing and distributing original children’s and family entertainment content in both 2D and CGI formats across TV, film and digital media platforms. Founded in 1995 by Marc du Pontavice, the award-winning Paris-based company owns a catalogue of more than 2,000 animated episodes and 3 feature films including strong brands such as Oggy & the Cockroaches, Zig & Sharko, The Daltons, Rolling with the Ronks and its first pre-school property, Paprika.
Broadcast in over 160 countries on all the major global children’s TV networks, these series are also breaking records on all the major digital platforms, including YouTube with over 250 million views per month, ranking Xilam as one of the top global content providers in animation.
Xilam employs more than 400 people, including 300 artists, who are based across its four studios located in Paris, Lyon, Angoulême and Hô-Chi-Minh Ville in Vietnam.
About Nazara Technologies
Nazara is a mobile games company headquartered in Mumbai, India and has operations in 61 countries across emerging markets, as on September 30, 2017. Nazara runs mobile gaming subscription services to mass mobile internet users comprising largely of first time mobile gamers across Africa, Middle East, South East Asia, Latin America and the Indian subcontinent. In India, Nazara has licensed mobile gaming rights to popular IP’s like Virat Kohli, Hrithik Roshan, Chhota Bheem, Royal Challengers Bangalore, Motu Patlu, Mighty Raju, Tinkle Characters and Chacha Choudhary.
Nazara was one of the leading publishers by downloads on Google Play Store with more than 22 million downloads in India in the calendar year 2016 and the company crossed over 34 million downloads in the calendar Year 2017 until September 30, 2017. Nazara had over 10 million monthly active users in September 2017 across its network of games on Google Play Store.
86 / 90 rue notre Dame de Nazareth 75003 Paris - Tél : (33) 01 40 18 72
00 - Fax : (33) 01 40 03 02 26
Société Anonyme au capital de 446 500 € - R.C.S PARIS : 423 784 610 - SIRET : 423 784 610 00036 - APE 921 A
Eva Pitarides, +44 20 7932 9800
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Rimini Street Launches New Solutions that Further Extend the Life and Value of Enterprise Software as a Foundation for Innovation24.4.2018 16:00 | Pressemelding
Rimini Street, Inc . (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced the first offerings in a family of solutions designed to provide improved competitive advantage to organizations with mature and valuable enterprise software investments that can be used as a foundation for innovation. Rimini Street’s new solutions can enable an organization to quickly and cost-effectively modernize their current enterprise software with the latest desired features and capabilities, future-proof their technical platforms against yet-unknown technology changes, and secure their systems against a constantly evolving threat environment. Rimini Street’s new solutions enable organizations to leverage their existing systems as a solid foundation for an innovative hybrid IT strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/
Novaliq to Present Scientific and Clinical Research During the 2018 Association for Research in Vision and Ophthalmology Meeting in Honolulu, HI24.4.2018 15:53 | Pressemelding
Novaliq GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, today announced that four scientific posters will be presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Meeting in Honolulu, HI (April 29-May 3). The variety of data to be presented reflects Novaliq’s dedication to science and clinical research. With the collection of posters, Novaliq will share clinical and pre-clinical data on its EyeSol® drug delivery technology and provide insights into the mode of action of its NOV03/NovaTears® water-free therapy for the treatment of dry eye disease (DED). Furthermore, Novaliq will present its first pre-clinical efficacy data in glaucoma. Scientific posters supported by Novaliq will include: “Influence of perfluorohexyloctane containing eye drops on tear film thickness in patients with mild to moderate dry eye disease.” Authors: Garhöfer G., Schm
Temasys Communications and Appian Partner to Power Real-Time Communications in the Contact Center24.4.2018 15:00 | Pressemelding
Temasys Communications announced today that Appian has integrated with the Temasys Skylink technology, enabling real-time communications, including chat and co-browsing, in Appian’s new Intelligent Contact Center (ICC) Platform. “For our contact center customers, omni-channel communications are essential. Appian is working with Temasys to provide contact centers with real-time communication channels such as chat and co-browsing via the Temasys versatile SDKs,” said Arturo Oliver, Senior Director of Product Strategy at Appian. Temasys Skylink APIs will be compatible with the Appian Intelligent Contact Center Platform, making it easy for Appian customers to add real-time communication to their applications, including chat, voice, video and co-browsing. These integrations enable users to visit a website, begin a chat session that seamlessly escalates to a voice call and extend to co-browsing — all without changing apps or establishing a new connection. “We’re thrilled to work with Appian
PPG Reports Sustainability Progress, New 2025 Goals24.4.2018 13:07 | Pressemelding
PPG (NYSE:PPG) today released its 2017 Corporate Sustainability Report, which details the company’s continued progress in strengthening its sustainable operations in 2017 and the launch of new, aggressive sustainability goals it aims to achieve by 2025. The report is available at sustainability.ppg.com. “PPG’s sustainability efforts go beyond product innovations to extend to our customers’ operations and the communities in which we operate,” said Mark Cancilla, PPG vice president, environment, health and safety. “We are encouraged by our progress in 2017 and excited about our new goals, which are representative of the challenges and opportunities of our current business portfolio.” The company achieved the following progress in 2017: 32 percent of sales from products that provide customers with a sustainable advantage, an increase of 60 percent since 2012. This includes the unveiling of multiple products that provide a sustainable solution, such as Sigma Air Pure, a revolutionary bio-b
Bioiberica Approves Its Combined Drug for Osteoarthritis in Five More European Countries24.4.2018 12:17 | Pressemelding
Bioiberica's combination of chondroitin sulphate and glucosamine hydrochloride, a slow action drug to treat osteoarthritis symptoms, was approved as an ethical drug in France, Austria, Hungary, Poland, and Finland through a mutual recognition process from Spain. ‘This approval confirms that Drug Agencies from different countries attest to the effectiveness and safety of the combination of pharmaceutical grade chondroitin sulphate and glucosamine hydrochloride. This drug has proven to reduce pain and improve mobility in people affected by knee osteoarthritis which, due to its safety profile, could also be used as an alternative by those patients with cardiovascular or gastrointestinal problems who should not be prescribed anti-inflammatory drugs chronically’, stated Dr Juan Gispert, Bioiberica's R&D director. The principle study that guarantees its effectiveness is the MOVES clinical trial, published in the Annals of the Rheumatic Diseases, which concludes that the combination of chondr
Asuragen to Present at World CB & CDx Europe Summit in London, UK24.4.2018 12:00 | Pressemelding
Asuragen, Inc., a molecular diagnostics company delivering easy to use products for complex testing in genetics and oncology, announced that its senior vice president of commercial operations, Colin Hill, will chair a roundtable discussion during the 2018 World Clinical Biomarkers & Companion Diagnostic (CB & CDx) Europe Summit taking place May 1-3 in London, UK. The session will focus on the imminent changes to the regulatory environment in Europe and the implications for pharmaceutical and diagnostic companies collaborating to advance precision medicine. “Precision medicine is becoming a reality around the world, and the regulations that guide it are rapidly evolving,” said Hill. “It is essential that we build close collaboration between the pharmaceutical, medical device and in vitro diagnostics industry if we are going to successfully navigate this new environment. While our success will definitely leverage learnings from the US experience, we will have to broaden our thinking as w